Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-27 Sale | 2026-08-31 5:05 pm | Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director | 400,000 | $4.04 | $1,616,000 | 5,277,216 (Indirect) | View |
| 2026-08-24 Sale | 2026-08-26 4:57 pm | Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director | 10 | $4.5 | $45 | 5,677,216 (Indirect) | View |
| 2026-08-19 Sale | 2026-08-21 4:59 pm | Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director | 191,865 | $4.5851 | $879,719 | 5,677,226 (Indirect) | View |
| 2026-08-18 Sale | 2026-08-20 5:59 pm | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 375,840 | $0.37333 | $140,313 | 7,850,155 (Indirect) | View |
| 2026-08-06 Sale | 2026-08-10 7:52 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 62,811 | $6.8751 | $431,829 | 3,877,094 (Indirect Direct) | View |
| 2026-07-30 Sale | 2026-08-03 5:32 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 116,474 | $6.9288 | $807,027 | 3,939,905 (Indirect Direct) | View |
| 2025-11-14 Sale | 2025-11-18 4:34 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 200,000 | $8.8 | $1,760,000 | 4,056,379 (Indirect Direct) | View |
| 2025-08-21 Sale | 2025-08-22 7:07 pm | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 231,405 | $3.4595 | $800,549 | 8,224,699 (Indirect) | View |
| 2025-07-09 Sale | 2025-07-11 5:25 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 27,000 | $7.502 | $202,554 | 4,256,379 (Indirect Direct) | View |
| 2025-06-27 Sale | 2025-07-01 8:32 pm | Entrada Therapeutics Inc. | TRDA | 5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 125,000 | $6.9331 | $866,633 | 4,283,379 (Indirect Direct) | View |
| 2024-10-15 Purchase | 2024-10-15 5:48 pm | Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director 10% Owner | 909,090 | $11 | $9,999,990 | 2,625,145 (Indirect) | View |
| 2024-09-11 Sale | 2024-09-13 6:56 pm | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 266,337 | $6.5719 | $1,750,352 | 66,277 (Indirect) | View |
| 2024-07-22 Purchase | 2024-07-24 4:15 pm | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 833,333 | $12 | $9,999,996 | 1,643,741 (Indirect) | View |
| 2024-02-14 Sale | 2024-02-16 4:15 pm | Enliven Therapeutics Inc. | ELVN | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 825,000 | $14.9 | $12,292,500 | 635,341 (Indirect) | View |
| 2024-01-31 Sale | 2024-02-02 4:29 pm | Enliven Therapeutics Inc. | ELVN | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 500,000 | $15 | $7,500,000 | 771,983 (Indirect) | View |
| 2023-09-26 Sale | 2023-09-28 4:27 pm | Enliven Therapeutics Inc. | ELVN | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 197,500 | $15 | $2,962,500 | 854,796 (Indirect) | View |
| 2023-08-24 Sale | 2023-08-28 4:20 pm | Enliven Therapeutics Inc. | ELVN | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 440,000 | $16 | $7,040,000 | 887,507 (Indirect) | View |
| 2023-04-10 Sale | 2023-04-12 4:51 pm | Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner | 16,544,113 | $0.12 | $1,985,294 | 200,000 (Indirect) | View |
| 2023-03-07 Sale | 2023-03-09 4:35 pm | Rallybio Corp | RLYB | 5AM Partners V LLC Schwab Andrew J. 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner | 100,000 | $8.2 | $820,000 | 3,630,724 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-10 Conversion | 2026-08-12 4:13 pm | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | 5AM Ventures VI L.P. 5AM Partners VI LLC 5AM Opportunities II L.P. 5AM Opportunities II (GP) LLC PARMAR KUSH Schwab Andrew J. 10% Owner | 14,651,924 | $0 | 2,350,419 (Indirect) | View |
Ownership | 2026-08-06 8:52 pm | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | 5AM Ventures VI L.P. 5AM Partners VI LLC 5AM Opportunities II L.P. 5AM Opportunities II (GP) LLC PARMAR KUSH Schwab Andrew J. 10% Owner | 0 | $0 | 7,325,962 (Indirect) | View |
| 2026-08-03 Option Award | 2026-08-05 5:29 pm | N/A N/A | Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director | 3,179,558 | $1.5299 | 3,179,558 (Indirect) | View |
| 2026-06-10 Option Award | 2026-06-12 4:16 pm | N/A 2036-06-09 | Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director 10% Owner | 28,000 | $0 | 28,000 (Direct) | View |
| 2026-03-31 Option Award | 2026-04-02 6:13 pm | N/A 2036-03-31 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2026-02-06 Option Award | 2026-02-09 9:06 pm | N/A 2036-02-06 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-09-11 Option Award | 2025-09-15 8:14 pm | N/A N/A | Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director 10% Owner | 2,941,176 | $1.53 | 5,869,091 (Indirect) | View |
| 2025-06-25 Option Award | 2025-06-27 4:02 pm | N/A 2035-06-24 | Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director 10% Owner | 9,000 | $0 | 9,000 (Direct) | View |
| 2025-02-24 Option Award | 2025-02-26 7:45 pm | N/A 2035-02-25 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-10-28 Option Award | 2024-10-30 8:30 pm | N/A 2034-10-27 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 70,000 | $0 | 70,000 (Direct) | View |
| 2024-10-15 Conversion | 2024-10-15 5:48 pm | N/A N/A | Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director 10% Owner | 24,661,577 | $0 | 2,625,145 (Indirect) | View |
Ownership | 2024-10-10 9:05 pm | N/A N/A | Camp4 Therapeutics Corp | CAMP | Schwab Andrew J. Director 10% Owner | 0 | $0 | 2,018,825 (Indirect) | View |
| 2024-07-22 Conversion | 2024-07-24 4:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 2,116,568 | $0 | 1,643,741 (Indirect) | View |
| 2024-07-22 Other | 2024-07-24 4:15 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 461,687 | $10.2 | 1,643,741 (Indirect) | View |
Ownership | 2024-07-18 8:06 pm | N/A N/A | Artiva Biotherapeutics Inc. | ARTV | 5AM Partners VI LLC 5AM Ventures VI L.P. PARMAR KUSH Schwab Andrew J. 10% Owner | 0 | $0 | 1,058,284 (Indirect) | View |
| 2024-03-13 Option Award | 2024-03-15 4:15 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 450,000 | $10 | 10,179,505 (Indirect) | View |
| 2024-02-29 Option Award | 2024-03-04 4:04 pm | N/A 2034-03-01 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 4:35 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 5,206,074 | $2.31 | 9,729,505 (Indirect) | View |
| 2023-11-06 Option Award | 2023-11-06 8:29 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 14,110 | $0 | 20,001 (Direct) | View |
| 2023-08-25 Option Award | 2023-08-29 9:36 pm | N/A 2033-08-25 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director | 1,472,692 | $0 | 1,472,692 (Direct) | View |
| 2023-08-18 Option Award | 2023-08-22 5:21 pm | 2023-08-18 2033-08-18 | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 704,509,037 | $0 | 443,296,919 (Indirect) | View |
| 2023-08-18 Option Award | 2023-08-22 5:21 pm | N/A N/A | Skye Bioscience Inc. | SKYE | Schwab Andrew J. Director 10% Owner | 852,696,240 | $0.0103 | 443,296,919 (Indirect) | View |
| 2023-02-23 Option Award | 2023-04-06 8:22 pm | N/A 2033-02-23 | Enliven Therapeutics Inc. | ELVN | Schwab Andrew J. Director 10% Owner | 27,567 | $0 | 27,567 (Direct) | View |
| 2023-02-24 Equity Swap | 2023-02-28 4:29 pm | N/A N/A | CinCor Pharma Inc. | CINC | 5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. 5AM Opportunities I (GP) LLC 10% Owner | 4,937,646 | $0 | 0 (Indirect) | View |